Is Marijuana Legal in Delaware?
Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated September 2026
Quick answer: Yes — fully legal for adults. Delaware legalized adult-use marijuana in 2023, and retail sales launched in August 2025. Adults 21 and older may possess up to one ounce, but home cultivation is prohibited. Employers may still enforce drug-free workplace policies and test employees.
Delaware at a glance
| Item | Status |
|---|---|
| Recreational (adult-use) legalization | 2023 |
| Medical program established | 2011 |
| Recreational possession limit | 1 oz |
| Recreational home cultivation | Not allowed |
Employer protections & drug testing
Delaware does not provide broad off-duty cannabis employment protections; employers may maintain drug-free workplace policies and test under state law.
Even in legal states, employers may still drug test and set workplace policies. Off-duty protections vary widely and federal-adjacent roles keep zero-tolerance.
What it means for a drug test
Delaware allows workplace drug testing and employers may act on positive results. State legalization does not override employer drug policies, and a medical card does not shield an employee from testing.
Sources
Status and limits verified against official state statutes and advocacy trackers. Laws change — always confirm with the primary source before relying on this page.
- Delaware Code (Title 16, Ch. 47)
- Delaware Office of the Marijuana Commissioner
- MPP state map
More states
See the full marijuana legality by state chart and the does weed show up on a drug test? guide.
Certified labs nationwide · Results in 1–2 days
Need a test? Order online, test same-day →People also ask
Do prescriptions count against me?
No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.
Sources & further reading
- SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
- DOT — 49 CFR Part 40 procedures for transportation workplace testing
- Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
- FDA — drug-of-abuse test device labeling (detection window conventions)